Your browser doesn't support javascript.
loading
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC.
Keegan, Alissa; Ricciuti, Biagio; Garden, Padric; Cohen, Limor; Nishihara, Reiko; Adeni, Anika; Paweletz, Cloud; Supplee, Julianna; Jänne, Pasi A; Severgnini, Mariano; Awad, Mark M; Walt, David R.
Afiliação
  • Keegan A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
  • Garden P; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Cohen L; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Nishihara R; Harvard University Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts, USA.
  • Adeni A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Paweletz C; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
  • Supplee J; Belfer Center for Applied Cancer Research, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
  • Jänne PA; Belfer Center for Applied Cancer Research, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
  • Severgnini M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
  • Awad MM; Belfer Center for Applied Cancer Research, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
  • Walt DR; Center for Immuno-Oncology, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA.
J Immunother Cancer ; 8(2)2020 10.
Article em En | MEDLINE | ID: mdl-33020238

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Interleucina-6 / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Interleucina-6 / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article